ENTITY

Shandong BoAn Biotechnology (6955 HK)

29
Analysis
Health Care • China
Shandong BoAn Biotechnology Co., Ltd. operates as a fully-integrated biopharmaceutical company. The Company specializes in the research and development, manufacturing and, commercialization of therapeutic antibodies, which are mainly focused on key therapeutic areas including oncology, metabolism, autoimmunity, and ophthalmology.
more
•23 Aug 2026 11:18

HSCI / HK Connect Sep 2026 Rebalance: Post-Announcement Positioning

HSIL announced the September review result on 21 Aug 2026 after market close. We forecast 53 southbound Connect ADDs and 15 DELETEs. We review the...

Logo
129 Views
Share
•06 Aug 2026 20:11

HSCI / HK Connect Sep 2026 Inclusion Forecast and Positioning

We expect 36 southbound Connect ADDs, 31 new and 5 returning, and 25 DELETEs from the current Connect list at the HSCI September review, effective...

Logo
162 Views
Share
bullish•Manycore Tech
•21 Jul 2026 16:48

HSCI / HK Connect Sep 2026 Rebalance Forecast

We forecast 44 ADD candidates and 26 DELETE candidates for the HSCI September review, with the announcement expected on 21 Aug 2026.

Logo
182 Views
Share
•08 Jul 2026 05:50

HSCI Index Rebalance Preview and Stock Connect (Sep 2026): Adds Outnumber Deletes as IPOs Dominate

There could be 80 changes for the HSCI in March. That could result in 70 changes to the Southbound Stock Connect list and also have implications...

Logo
237 Views
Share
•28 Jun 2026 10:05

HK Connect Flows Weekly (Jun 26th): Kingboard, Alibaba, Kingboard Laminates, Smic, Tencent, CNOOC

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Kingboard (148 HK), Alibaba (9988 HK), Kingboard...

Logo
131 Views
Share
x